Join
Live feed
·
INSIDERFilingvia Quantisnow
Hepion Pharmaceuticals Inc. logo

Wijngaard Peter bought $15,350 worth of shares (5,000 units at $3.07), increasing direct ownership by 111% to 9,501 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HEPA· Hepion Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HEPA (Hepion Pharmaceuticals Inc.) and more on Quantisnow.